Acute toxic leukoencephalopathy: Potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging

American Journal of Roentgenology

Volumn 193, Issue 1, 2009, Pages 192-206

  McKinney, Alexander M ^a   Kieffer, Stephen A ^a   Paylor, Rogerich T ^a   SantaCruz, Karen S ^a   Kendi, Ayse ^a   Lucato, Leandro ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Diffusion weighted MRI; FLAIR; Leukoencephalopathy; MRI; Toxic leukoencephalopathy; White matter

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CHILD; CLINICAL ARTICLE; CONGENITAL DISORDER; CORRELATION COEFFICIENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; FEMALE; FOLLOW UP; GENETIC DISORDER; HISTOLOGY; HUMAN; HUMAN TISSUE; LEUKOENCEPHALOPATHY; MALE; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SYMPTOM; WHITE MATTER; ADOLESCENT; COMPUTER ASSISTED DIAGNOSIS; ENCEPHALOMYELITIS; METHODOLOGY; MIDDLE AGED; REMISSION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; CHILD; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LEUKOENCEPHALITIS, ACUTE HEMORRHAGIC; MALE; MIDDLE AGED; REMISSION, SPONTANEOUS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 67650338041     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1176     Document Type: Article

References (59)

1. Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med 2001; 345:425-432
2. Sandoval C, Kutscher M, Jayabose S, et al. Neurotoxicity of intrathecal methotrexate: MR imaging findings. Am J Neuroradiol 2003; 24:1887-1890 (Pubitemid 37280543)
3. Rollins N, Winick N, Bash R, et al. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. Am J Neuroradiol 2004; 25:1688-1695 (Pubitemid 44123692)
4. Fisher MJ, Khademian ZP, Simon EM, et al. Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. Am J Neuroradiol 2005; 26:1686-1689 (Pubitemid 43853664)
5. Tha KK, Terae S, Sugiura M, et al. Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy. Acta Neurol Scand 2002; 106:379-386 (Pubitemid 36020748)
6. Lucato LT, McKinney AM, Short J, et al. Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity. Australas Radiol 2006; 50:364-368 (Pubitemid 44086734)
7. Aydin K, Donmez F, Tuzun U, et al. Diffusion MR findings in cyclosporin-A induced encephalopathy. Neuroradiology 2004; 46:822-824 (Pubitemid 39534610)
8. Wartenberg KE, Patsalides AD, Yepes M. Transient diffusion-weighted imaging changes in a patient with reversible leukoencephalopathy syndrome. Acta Radiol 2004; 45:674-678 (Pubitemid 44112737)
9. Kim DW, Park JM, Yoon BW, et al. Metronidazole-induced encephalopathy. J Neurol Sci 2004; 224:107-111
10. Seok JI, Yi H, Song YM, et al. Metronidazole-induced encephalopathy and inferior olivary hypertrophy: lesion analysis with diffusion-weighted imaging and apparent diffusion coefficient maps. Arch Neurol 2003; 60:1796-1800 (Pubitemid 37521640)
11. Keogh CF, Andrews GT, Spacey SD, et al. Neuroimaging features of heroin inhalation toxicity: "chasing the dragon." AJR 2003; 180:847-850
12. Chen CY, Lee KW, Lee CC, et al. Heroin-induced spongiform leukoencephalopathy: value of diffusion MR imaging. J Comput Assist Tomogr 2000; 24:735-737 (Pubitemid 32204303)
13. Teksam M, Casey SO, Michel E, Liu H, Truwit CL. Diffusion-weighted MR imaging findings in carbon monoxide poisoning. Neuroradiology 2002; 44:109-113 (Pubitemid 36075895)
14. 1H-magnetic resonance spectroscopy. J Neurol Neurosurg Psychiatry 2001; 71:250-253
15. Molloy S, Soh C, Williams TL. Reversible delayed posthypoxic leukoencephalopathy. Am J Neuroradiol 2006; 27:1763-1765
16. Finelli PF, DiMario FJ Jr. MR imaging and prognosis of hypoxic-ischemic leukoencephalopathy. Neurocrit Care 2006; 4:119-126
17. Roychowdhury S, Maldjian JA, Galetta SL, et al. Postanoxic encephalopathy: diffusion MR findings. J Comput Assist Tomogr 1998; 22:992-994
18. Arbelaez A, Castillo M, Mukherji SK. Diffusion-weighted MR imaging of global cerebral anoxia. Am J Neuroradiol 1999; 20:999-1007 (Pubitemid 29536205)
19. Chalela JA, Wolf RL, Maldjian JA, et al. MRI identification of early white matter injury in anoxic-ischemic encephalopathy. Neurology 2001; 56:481-485 (Pubitemid 32172872)
20. Sener RN. Diffusion magnetic resonance imaging patterns in metabolic and toxic brain disorders. Acta Radiol 2004; 45:561-570 (Pubitemid 44112211)
21. Patay Z. Diffusion-weighted MR imaging in leukodystrophies. Eur Radiol 2005; 15:2284-2303
22. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR 2007; 189:904-912 (Pubitemid 47485623)
23. Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR 2000; 21:1199-1206 (Pubitemid 30655653)
24. Welzel T, Niethammer A, Mende U, et al. Diffusion tensor imaging screening of radiation-induced changes in the white matter after prophylactic cranial irradiation of patients with small cell lung cancer: first results of a prospective study. AJNR 2008; 29:379-383 (Pubitemid 351287900)
25. Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol 2006; 111:197-212
26. Moore-Maxwell CA, Datto MB, Hulette CM. Chemotherapy-induced toxic leukoencephalopathy causes a wide range of symptoms: a series of four autopsies. Mod Pathol 2004; 17:241-247 (Pubitemid 41656522)
27. Quinn CT, Griener JC, Bottiglieri T, et al. Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid. J Pediatr Hematol Oncol 2004; 26:386-388 (Pubitemid 38747731)
28. Shibutani M, Okeda R. Experimental study on subacute neurotoxicity of methotrexate in cats. Acta Neuropathol 1989; 78:291-300 (Pubitemid 19182494)
29. Akiba T, Okeda R, Tajima T. Metabolites of 5-fluorouracil, alpha-fluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture. Acta Neuropathol 1996; 92:8-13 (Pubitemid 26192076)
30. Okeda R, Shibutani M, Matsuo T, et al. Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic-acid and alpha-fluoro-beta-alanine. Acta Neuropathol 1990; 81:66-73 (Pubitemid 20377478)
31. Wijdicks EF. Neurotoxicity of immunosuppressive drugs. Liver Transpl 2001; 7:937-942
32. Munoz R, Espinoza M, Espinoza O, et al. Cyclosporine-associated leukoencephalopathy in organ transplant recipients: experience of three clinical cases. Transplant Proc 2006; 38:921-923
33. Wilasrusmee C, Da Silva M, Singh B, et al. Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction. Clin Transplant 2003; 17[suppl 9]:6-12 (Pubitemid 36958178)
34. Heaney CJ, Campeau NG, Lindell EP. MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxic ity. Am J Neuroradiol 2003; 24:1615-1617 (Pubitemid 37151730)
35. Ahmed A, Loes DJ, Bressler EL. Reversible magnetic resonance imaging findings in metronidazole-induced encephalopathy. Neurology 1995; 45:588-589
36. Rao DN, Mason RP. Generation of nitro radical anions of some 5-nitrofurans, 2- and 5-nitroimidazoles by norepinephrine, dopamine, and serotonin: a possible mechanism for neurotoxicity caused by nitroheterocyclic drugs. J Biol Chem 1987; 262:11731-11736 (Pubitemid 17128688)
37. Kinoshita T, Sugihara S, Matsusue E, et al. Pallidoreticular damage in acute carbon monoxide poisoning: diffusion-weighted MR imaging findings. Am J Neuroradiol 2005; 26:1845-1848 (Pubitemid 43853690)
38. Kim JH, Chang KH, Song IC, et al. Delayed encephalopathy of acute carbon monoxide intoxication: diffusivity of cerebral white matter lesions. Am J Neuroradiol 2003; 24:1592-1597 (Pubitemid 37151725)
39. Lapresle J, Fardeau M. The central nervous system and carbon monoxide poisoning. II. Anatomical study of brain lesions following intoxication with carbon monoxide (22 cases). Prog Brain Res 1967; 24:31-74
40. Ryan A, Molloy FM, Farrell MA, et al. Fatal toxic leukoencephalopathy: clinical, radiological, and necropsy findings in two patients. J Neurol Neurosurg Psychiatry 2005; 76:1014-1016 (Pubitemid 40909567)
41. Funata N, Okeda R, Takano T, et al. Electron microscopic observations of experimental carbon monoxide encephalopathy in the acute phase. Acta Pathol Jpn 1982; 32:219-229 (Pubitemid 13229313)
42. Miese F, Kircheis G, Wittsack HJ, et al. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. Am J Neuroradiol 2006; 27:1019-1026 (Pubitemid 44897679)
43. Ranjan P, Mishra AM, Kale R, et al. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis 2005; 20:181-192 (Pubitemid 41355608)
44. Kato M, Sugihara J, Nakamura T, et al. Electron microscopic study of the blood-brain barrier in rats with brain edema and encephalopathy due to acute hepatic failure. Gastroenterol Jpn 1989; 24:135-142 (Pubitemid 19162222)
45. Ahl B, Weissenborn K, van den Hoff J, et al. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 2004; 40:73-79 (Pubitemid 38868925)
46. Lockwood AH, Ginsberg MD, Rhoades HM, et al. Cerebral glucose metabolism after portacaval shunting in the rat: patterns of metabolism and implications for the pathogenesis of hepatic encephalopathy. J Clin Invest 1986; 78:86-95 (Pubitemid 16068185)
47. Bartynski WS, Zeigler Z, Spearman MP, et al. Etiology of cortical and white matter lesions in cyclosporin A and FK-506 neurotoxicity. Am J Neuroradiol 2001; 22:1901-1914 (Pubitemid 33091961)
48. Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR 2008; 29:447-455
49. Wintermark M, Fischbein NJ, Mukherjee P, et al. Unilateral putaminal CT, MR, and diffusion abnormalities secondary to nonketotic hyperglycemia in setting of acute neurologic symptoms mimicking stroke. Am J Neuroradiol 2004; 25:975-976 (Pubitemid 38765877)
50. Shan DE. An explanation for putaminal CT, MR, and diffusion abnormalities secondary to nonketotic hyperglycemia. Am J Neuroradiol 2005; 26:194-195 (Pubitemid 43079848)
51. Baumann M, Korenke GC, Weddige-Diedrichs A, et al. Hematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy. Eur J Pediatr 2003; 162:6-14 (Pubitemid 35478203)
52. Shapiro E, Krivit W, Lockman L, et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 2000; 356:713-718 (Pubitemid 30663240)
53. Helenius J, Soinne L, Perkiö J, et al. Diffusion-weighted MR imaging in normal human brains in various age groups. AJNR 2002; 23:194-199 (Pubitemid 34160422)
54. Bilgili Y, Unal B. Effect of region of interest on interobserver variance in apparent diffusion coefficient measures. AJNR 2004; 25:108-111 (Pubitemid 38129488)
55. Zhai G, Lin W, Wilber KP, Gerig G, Gilmore JH. Comparisons of regional white matter diffusion in healthy neonates and adults performed with a 3.0-T head-only MR imaging unit. Radiology 2003; 229:673-681 (Pubitemid 37467568)
56. Huisman TA, Loenneker T, Barta G, et al. Quantitative diffusion tensor MR imaging of the brain: field strength related variance of apparent diffusion coefficient (ADC) and fractional anisotropy (FA) scalars. Eur Radiol 2006; 16:1651-1658 (Pubitemid 44027365)
57. Reddick WE, Glass JO, Helton KJ, et al. A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation. AJNR 2005; 26:2371-2377
58. Baehring JM, Fulbright RK. Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients. J Neurol Neurosurg Psychiatry 2008; 79:535-539 (Pubitemid 351571871)
59. Grant PE, He J, Halpern EF, et al. Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain. Radiology 2001; 221:43-50 (Pubitemid 32880369)